← Back to catalogue

SARS-CoV-2 And Influenza A/B Antigen Combo Test

EUDAMED

Class IVD General (EU MDR)

Ref SIAg-1,SIAg-5,SIAg-25,SIAg02-1,SIAg02-5,IAg02-25

by TargetingOne Technology (Beijing) Corporation

Identity

Trade Name
SARS-CoV-2 And Influenza A/B Antigen Combo Test EUDAMED
Model / Reference
SIAg-1,SIAg-5,SIAg-25,SIAg02-1,SIAg02-5,IAg02-25 EUDAMED

Identifiers

Primary DI / UDI-DI
06974689626186 EUDAMED
Basic UDI-DI
B-06974689626186 EUDAMED
EMDN Code
W0105099099 VIROLOGY - RT & POC - OTHER EUDAMED

Classification

Device Class
Class IVD General EUDAMED
Market of Registration
Finland EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

SARS-CoV-2 And Influenza A/B Antigen Combo Test by TargetingOne Technology (Beijing) Corporation — Class IVD General — IVDD — listed in EUDAMED

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000028247
Authorised Representative
SUNGO Europe B.V. NL-AR-000000247

Sources (1)

  • EUDAMED 8799b839-772c-4297-8d9b-093718369a53 61 fields · synced Jun 18, 2026